Jodi Akin is the Founder, Chairman and CEO of Hawthorne Effect, a complete clinical trials solution integrating technology and people to make clinical trials accessible and convenient for every patient and deliver meaningful and high-quality clinical assessments for investigators. Jodi has over 30 years in the medical space and is an angel Investor for more than a dozen start-ups. She has been a Board member for 510 Kardiac Devices, Inc., Vasconnect Inc., NovoVascular, Inc. and preEminent, LLC, and served as the chief scientific advisor for PiCardia, Inc. Previously, as co-inventor of medical devices, J...read more